Education
About Us
Working with TipRanks
Follow Us
Spruce Biosciences (SPRB)
NASDAQ:SPRB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.91M | $ 10.09M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 4.91M | $ -39.34M | $ -429.00K | $ -381.00K | $ -102.00K |
| Operating Income | $ -56.15M | $ -51.99M | $ -47.28M | $ -42.07M | $ -29.42M |
| EBITDA | $ -56.15M | $ -47.37M | $ -45.33M | $ -41.57M | $ -29.11M |
| Net Income | $ -53.04M | $ -47.92M | $ -45.08M | $ -42.69M | $ -30.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 38.75M | $ 96.34M | $ 79.08M | $ 88.97M | $ 157.15M |
| Total Assets | $ 45.21M | $ 103.95M | $ 85.65M | $ 126.49M | $ 162.88M |
| Total Debt | $ 2.36M | $ 4.61M | $ 6.18M | $ 6.17M | $ 6.13M |
| Net Debt | $ -36.40M | $ -91.73M | $ -18.31M | $ -36.58M | $ -151.02M |
| Total Liabilities | $ 16.39M | $ 27.44M | $ 17.16M | $ 15.12M | $ 13.46M |
| Stockholders' Equity | $ 28.82M | $ 76.51M | $ 68.49M | $ 111.37M | $ 149.43M |
| Cash Flow | |||||
| Free Cash Flow | $ -55.96M | $ -33.28M | $ -41.69M | $ -35.97M | $ -27.59M |
| Operating Cash Flow | $ -55.96M | $ -33.27M | $ -41.68M | $ -35.88M | $ -27.52M |
| Investing Cash Flow | $ 0.00 | $ 55.78M | $ 23.69M | $ -79.17M | $ -74.00K |
| Financing Cash Flow | $ -1.62M | $ 49.14M | $ -241.00K | $ 643.00K | $ 181.03M |
Spruce Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.